This invention relates to combinations of therapeutic molecules useful for treating hepatitis C virus infection. The present invention relates to methods, uses, dosing regimens, and compositions.
申请公布号
KR20140096029(A)
申请公布日期
2014.08.04
申请号
KR20147009860
申请日期
2012.09.14
申请人
GILEAD PHARMASSET LLC
发明人
RAY ADRIAN S.;WATKINS WILLIAM J.;LINK JOHN O.;OLDACH DAVID W.;DELANEY IV WILLIAM E.
